Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Vitamin E can reduce the negative effects of valproic acid on hair and skin development.

Tridax procumbens L. has compounds that can fight fungi.

Finasteride delivery through skin improved using invasomes and iontophoresis.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Topical ruxolitinib quickly improves non-segmental vitiligo.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

A cat had a rare severe reaction to fenbendazole, but recovered with treatment.

Eflornithine's effectiveness for women with facial hirsutism is unclear.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Children taking higher doses of valproic acid had lower biotinidase activity, which may lead to biotin deficiency, but biotin supplements could help.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Vaccination and hygiene are key to preventing Feline Calicivirus in cats.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Ixekizumab has known and some unexpected side effects.